Louise Bier, MS
About Me
As a genetic counselor, Louise Bier, MS, CGC, has worked at the interface of clinical care and genetics research. Her previous work has focused on lysosomal storage disorders and related clinical research and clinical trials, as well as genomics research and precision medicine with a particular focus on epilepsy and other neurologic disorders. Through collaboration with geneticists and clinicians, Ms. Bier has contributed to efforts identifying new gene/disease associations and expanding known gene/disease phenotypes, including GNB1, SCN8A, CSNK2B, and SPTBN1. She has also worked extensively on educating and engaging communities across New York City on the topic of precision medicine research and is a co-author on the NSGC’s Practice Resource on Elective Genomic Testing.
Currently, as Director of Clinical Trials in Genetics & Genomic Sciences, Ms. Bier partners with clinical investigators to oversee the implementation of clinical trials for rare genetic diseases. She also serves as the Director of Clinical Research for the ISMMS Master’s in Genetic Counseling program.
Language
English
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Bier has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.